Role of Non-Coding Rnas As New Therapeutic Targets in Regulating the Emt and Apoptosis in Metastatic Gastric and Colorectal Cancers Publisher Pubmed



Ebrahimi N¹ ; Hakimzadeh A² ; Bozorgmand F³ ; Speed S⁴ ; Manavi MS⁵ ; Khorram R⁶ ; Farahani K⁷ ; Rezaeitazangi F⁸ ; Mansouri A⁹ ; Hamblin MR^{10, 11} ; Aref AR^{12, 13}
Source: Cell Cycle Published:2023

Abstract

Colorectal cancer (CRC) and gastric cancer (GC), are the two most common cancers of the gastrointestinal tract, and are serious health concerns worldwide. The discovery of more effective biomarkers for early diagnosis, and improved patient prognosis is important. Non-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), can regulate cellular processes such as apoptosis and the epithelial-mesenchymal transition (EMT) leading to progression and resistance of GC and CRC tumors. Moreover these pathways (apoptosis and EMT) may serve as therapeutic targets, to prevent metastasis, and to overcome drug resistance. A subgroup of ncRNAs is common to both GC and CRC tumors, suggesting that they might be used as biomarkers or therapeutic targets. In this review, we highlight some ncRNAs that can regulate EMT and apoptosis as two opposite mechanisms in cancer progression and metastasis in GC and CRC. A better understanding of the biological role of ncRNAs could open up new avenues for the development of personalized treatment plans for GC and CRC patients. © 2023 Informa UK Limited, trading as Taylor & Francis Group.